Citation Impact
Citing Papers
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Multimodal data and machine learning for surgery outcome prediction in complicated cases of mesial temporal lobe epilepsy
2015
College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: the clinical use and laboratory monitoring of low-molecular-weight heparin, danaparoid, hirudin and related compounds, and argatroban.
1998
Anti-Xa activity after subcutaneous administration of dalteparin in ICU patients with and without subcutaneous oedema: a pilot study
2006
Parenteral Anticoagulants
2012 Standout
Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage
2009
Action Plan for Stroke in Europe 2018–2030
2018 Standout
Antithrombotic Therapy for Venous Thromboembolic Disease
2008 Standout
Astrocytes: Implications for Neuroinflammatory Pathogenesis of Alzheimers Disease
2011
Lack of effect of a low-molecular-weight heparin (nadroparin) on mortality in bedridden medical in-patients: a prospective randomised double-blind study
2005
Subcutaneous Enoxaparin Once or Twice Daily Compared with Intravenous Unfractionated Heparin for Treatment of Venous Thromboembolic Disease
2001
Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety
2001 Standout
Contribution of platelets to tumour metastasis
2011 Standout
Is Impaired Renal Function a Contraindication to the Use of Low-Molecular-Weight Heparin?
2002
Anti-cancer properties of low-molecular-weight heparin: Preclinical evidence
2009
No Difference in Risk for Thrombocytopenia During Treatment of Pulmonary Embolism and Deep Venous Thrombosis With Either Low-Molecular-Weight Heparin or Unfractionated Heparin
2007
Safety, pharmacodynamics, and pharmacokinetics of BAY 59-7939—an oral, direct Factor Xa inhibitor—after multiple dosing in healthy male subjects
2005
Perioperative Management of Antithrombotic Therapy
2012 Standout
Oral Anticoagulant Therapy
2012 Standout
Antithrombotic Therapy for VTE Disease
2016 Standout
Combined Screening With Ultrasound and Mammography vs Mammography Alone in Women at Elevated Risk of Breast Cancer
2008 Standout
Unresolved issues in anticoagulant therapy
2003
Treatment and Prevention of Heparin-Induced Thrombocytopenia
2008 Standout
An RNA-Sequencing Transcriptome and Splicing Database of Glia, Neurons, and Vascular Cells of the Cerebral Cortex
2014 Standout
Laboratory Measurement of the Anticoagulant Activity of the Non–Vitamin K Oral Anticoagulants
2014
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
2011 Standout
Prevention of VTE in Nonsurgical Patients
2012 Standout
Antithrombotic Therapy for VTE Disease
2012 Standout
Brown-Sequard syndrome after blunt cervical spine trauma: clinical and radiological correlations
2007
Prevention of VTE in Nonorthopedic Surgical Patients
2012 Standout
The Pharmacokinetics of Subcutaneous Enoxaparin in End‐Stage Renal Disease
2001
Explainable machine-learning predictions for the prevention of hypoxaemia during surgery
2018 Standout
Neuroimaging in Traumatic Spinal Cord Injury: An Evidence-based Review for Clinical Practice and Research
2007
Prevention of Venous Thromboembolism
2004 Standout
Pharmacokinetics and pharmacodynamics of the prophylactic dose of enoxaparin once daily over 4 days in patients with renal impairment
2002
The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition
2016 Standout
Interplay between Cortical Spreading Depolarization and Seizures
2017 Standout
Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty
2008 Standout
Changes in the pharmacokinetics of the low-molecular-weight heparin enoxaparin sodium during pregnancy
1999
Prevention of Venous Thromboembolism
2008 Standout
Anti-Xa activity in obese patients after double standard dose of nadroparin for prophylaxis
2002
Traumatic spinal cord injury
2017 Standout
Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy
2009 Standout
Bridging anticoagulation with low-molecular-weight heparin after interruption of warfarin therapy is associated with a residual anticoagulant effect prior to surgery
2005
Antithrombotic Therapy for Venous Thromboembolic Disease
2001 Standout
Changes in Enoxaparin Pharmacokinetics During Pregnancy and Implications for Antithrombotic Therapeutic Strategy
2008
Postoperative nadroparin administration for prophylaxis of thromboembolic events is not associated with an increased risk of hemorrhage after spinal surgery
2004
Effects of the oral, direct factor Xa inhibitor rivaroxaban on commonly used coagulation assays
2010 StandoutNobel
Antithrombotic Therapy for Venous Thromboembolic Disease
2004 Standout
Outpatient treatment of deep vein thrombosis: translating clinical trials into practice
1999
Pharmacokinetics and Pharmacodynamics of Enoxaparin in Multiple Trauma Patients
2005
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Risk of Postoperative Hemorrhage after Intracranial Surgery after Early Nadroparin Administration: Results of a Prospective Study
2003
Open Multicentre Study of the P 2T Receptor Antagonist AR-C69931MX Assessing Safety, Tolerability and Activity in Patients with Acute Coronary Syndromes
2001
Anticoagulation: Low-Molecular-Weight Heparins in Renal Impairment and Obesity: Available Evidence and Clinical Practice Recommendations Across Medical and Surgical Settings
2009
Tinzaparin and enoxaparin given at prophylactic dose for eight days in medical elderly patients with impaired renal function
2007
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
Guidelines for Adult Stroke Rehabilitation and Recovery
2016 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage
2012 Standout
Family history of subarachnoid haemorrhage: supplemental value of scrutinizing all relatives.
1997 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack
2010 Standout
Works of F. Collignon being referenced
Acute traumatic central cord syndrome: magnetic resonance imaging and clinical observations
2002
Comparative effects of enoxaparin and unfractionated heparin in healthy volunteers on prothrombin consumption in whole blood during coagulation, and release of tissue factor pathway inhibitor
1993
Long-term outcome of epilepsy surgery among 399 patients with nonlesional seizure foci including mesial temporal lobe sclerosis
2006
Comparison of the Pharmacokinetic Profiles of Three Low Molecular Mass Heparins – Dalteparin, Enoxaparin and Nadroparin – Administered Subcutaneously in Healthy Volunteers (Doses for Prevention of Thromboembolism)
1995
Serum Magnesium Levels as Related to Symptomatic Vasospasm and Outcome Following Aneurysmal Subarachnoid Hemorrhage
2004
Altered expression of connexin subtypes in mesial temporal lobe epilepsy in humans
2006
Pharmacokinetics of enoxaparin in man given single subcutaneous doses of 1.0-1.25–1.50-2.0 mg/kg
1992